Product Images Aripiprazole

This text provides information on the effect of other drugs on Aripiprazole, including inhibitors, inducers, and blockers. The included drugs are Etoconazole, Quinidine, Carbamazepine, Famotidine, and Lorazepam. The text also includes a chart showing the fold change and 90% confidence intervals for changes in Aripiprazole relative to a reference, without the interacting drug.*

This is a table showing the effect of different drugs on the drug Aripiprazole. The drugs are categorized as inhibitors or inducers of enzymes that affect the metabolism of Aripiprazole. The inhibitors include Ketoconazole and Y206 Inhibitor, while the inducer is Carbamazepine. Other drugs such as Famotine, Vaproae, Hum Auc, and Lorazepam are also mentioned. The table also shows the fold change and percentage of change of Aripiprazole with and without interacting drugs.*

This text describes a chart or table showing the effect of aripiprazole on other drugs. It identifies specific drugs and enzymes such as CYP2D6, UGT1A4, and dextromethorphan, and indicates their fold change and 90% confidence interval. It also features a graph with data points ranging from 0 to 25 on the x-axis and a change relative to the reference on the y-axis.*

This text appears to be describing different subgroups or populations based on various characteristics such as metabolizer status, gender, age, and liver/renal impairment. There is also a mention of "Avipiprazole Fold Change" with some corresponding data points. It is unclear what the purpose of this description is or how the information may be used without additional context.*

This seems to be a chart or graph showing the proportion of patients who experienced a relapse during a treatment with Avipiprazole compared to a placebo. The x-axis shows the number of days from randomization and the y-axis shows the percentage of patients. The data is presented in two lines, one for Avipiprazole and one for the placebo, with dots indicating the percentage of patients experiencing a relapse at each time point.*

The given text seems to be a chart representing the relapse proportions for subjects treated with Aripiprazole and Placebo. The chart shows the proportion of subjects that relapse over time, with the number of subjects at risk noted below the chart. The x-axis represents the number of days from randomization, and the y-axis represents the proportion with relapse. A useful interpretation of the chart is not possible without additional context about the study.*

This is a prescription drug with NDC number 50436-0897-1 called Aripiprazole Tablets, USP. Each tablet contains 5mg of the medication. The packaging quantity is 50 tablets per pack. Additional information about the drug and its usage is not available.*